CanSino Biologics follows Sinopharm and Sinovac Biotech in winning WHO approval for their coronavirus vaccines. Photo: Shutterstock
CanSino Biologics follows Sinopharm and Sinovac Biotech in winning WHO approval for their coronavirus vaccines. Photo: Shutterstock

3rd Chinese Covid-19 vaccine gets WHO nod, as CanSino viral vector jab cleared for emergency use

  • Thursday’s WHO announcement follows similar listings last year for vaccines from Sinopharm and Sinovac Biotech
  • UN agency says the vaccine is 64 per cent effective against symptomatic disease and 92 per cent against severe cases

CanSino Biologics follows Sinopharm and Sinovac Biotech in winning WHO approval for their coronavirus vaccines. Photo: Shutterstock
CanSino Biologics follows Sinopharm and Sinovac Biotech in winning WHO approval for their coronavirus vaccines. Photo: Shutterstock
READ FULL ARTICLE